# Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease Patients

> **NCT00852020** · NA · COMPLETED · sponsor: **Fresenius Kabi** · enrollment: 60 (actual)

## Conditions studied

- Cachexia
- Chronic Obstructive Pulmonary Disease
- Chronic Heart Failure

## Interventions

- **DIETARY_SUPPLEMENT:** oral nutrition supplement, food for special medical purposes

## Key facts

- **NCT ID:** NCT00852020
- **Lead sponsor:** Fresenius Kabi
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00852020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00852020, "Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease Patients". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT00852020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*